IX Biopharma has entered into an agreement with independent third party Eurofins Australia New Zealand Holding for the proposed disposal of its entire stake in its wholly-owned subsidiary, ...

PHARMACEUTICAL company iX Biopharma has sunk deeper into the red with a net loss of S$3.7 million for the second quarter ending Dec 31, 2018 from a net loss of S$3.2 million a year ago. For the...